Citadel Advisors »

Kala Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Kala Pharmaceuticals (KALA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Kala Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kala Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $31k 56k 0.56
2024-03-31 $106k 14k 7.84

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Kala Pharmaceuticals

Baker Bros. Advisors
Woodline Partners
Jane Street
ADAR1 Capital Management
Vanguard Group
Virtu Financial
Geode Capital Management
Citadel Advisors
Renaissance Technologies
State Street Corporation
XTX Topco
Two Sigma Investments
UBS Group
BlackRock
Grant Private Wealth Management

View all funds holding Kala Pharmaceuticals